Figure 6From: Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicityEffects of combined treatment with antisense clusterin oligonucleotide (ODNclu) (at 100 and 500 nM) and tamoxifen (10-7 M) on cytotoxicity of the MCF-7 cell line. The same treatment schedule described in figure 3 was followed. **p < 0.01; ***p < 0.001. ODNc, control oligonucleotide.Back to article page